Deputy Director
https://www.niams.nih.gov/es/node/10741
The NIAMS Deputy Director page features information about Dr. Anna E. Mazzucco.
Displaying 861 - 880 of 1020 results
Executive Officer and Associate Director for Management and Operations
https://www.niams.nih.gov/es/node/10746
This is the Associate Director for Management and Operations and Executive Officer page, featuring Rick Phillips
Director of the Division of Extramural Research
https://www.niams.nih.gov/es/node/10751
Gayle Lester, Ph.D. Dr. Gayle Lester is director of the Division of Extramural Research (DER). Dr. Lester held the position in an acting role following the reorganization of the NIAMS extramural program in April 2018. She assumed the director position in March 2020. In addition to her programmatic management of
Scientific Director
https://www.niams.nih.gov/es/node/10761
The Office of the Scientific Director (OSD) is responsible for oversight, review, and administration of the Intramural Research Program (IRP) at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The OSD has several key functions, including planning, coordinating, and directing the basic and clinical scientific research programs conducted within the IRP.
Accelerating Medicines Partnership® Autoimmune and Immune-Mediated Diseases (AMP® AIM) Program
https://www.niams.nih.gov/es/node/10786
The Accelerating Medicines Partnership® Autoimmune and Immune-Mediated Diseases (AMP® AIM) program launched in 2021 with the goal of deepening our understanding of the cellular and molecular interactions that lead to inflammation and autoimmune diseases.
NIAMS HIV/AIDS Program
https://www.niams.nih.gov/es/node/11221
Overview While the success of antiretroviral therapies continues to improve the life expectancy of people living with HIV/AIDS (PLWHA), both aging and HIV-treatment are associated with the early appearance or greater risk of comorbidities that affect the musculoskeletal system and skin. In order to address the mechanisms underlying these changes
Collaboration and Innovation: Looking Back and Ahead on NIAMS’ 35th Anniversary
https://www.niams.nih.gov/es/node/11226
As I settle into my new role as director of NIAMS, I have the honor of leading the Institute on its 35th anniversary.
Manasi Gadkari, M.S.
https://www.niams.nih.gov/es/node/11236
Manasi Gadkari, M.S., is a Senior Research Associate in the Functional Immunogenomics Unit at the NIAMS. Her research focuses on understanding and studying glucocorticoid-mediated immunoregulation.
Research: Neutrophils Initiate and Exacerbate Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
https://www.niams.nih.gov/es/node/11266
New research published in the journal Science Translational Medicine uncovers how neutrophils contribute to disease pathophysiology of Stevens-Johnson syndrome and toxic epidermal necrolysis, which are life-threatening mucocutaneous adverse drug reactions.
Casting the NET Wide: How Neutrophils Shape Chronic Autoimmune and Inflammatory Diseases
https://www.niams.nih.gov/es/node/11506
Known as the “disease with a thousand faces,” systemic lupus erythematosus is a lifelong autoimmune disease with a wide range of symptoms and signs—fatigue, fever, joint pain, facial rash and skin lesions, shortness of breath, and more. It may develop suddenly or slowly and be mild or severe, with people affected going through periods of flare up and remission of their symptoms.
Ahsan Polash, Ph.D.
https://www.niams.nih.gov/es/node/11516
Dr. Polash is a computational biologist in Dr. Hafner’s group. His current research focuses on studying transcriptional regulation through RNA-binding proteins.
Drugs treat spinal disc degeneration in mice
https://www.niams.nih.gov/es/node/11551
A research team led by Dr. Makarand Risbud of Thomas Jefferson University tested whether treatment with the drugs dasatinib and quercetin would prevent disc degeneration in mice. Both drugs are senolytics, which selectively remove aged cells known as senescent cells.
Norio Hanata, M.D., Ph.D.
https://www.niams.nih.gov/es/node/11566
Norio Hanata, M.D., Ph.D., is a rheumatologist from Japan. He is a postdoctoral visiting fellow in the Systemic Autoimmunity Branch at the NIAMS. His research focuses on understanding the pathogenic roles of neutrophils in systemic autoimmune diseases.
Mubarak Umar, Ph.D.
https://www.niams.nih.gov/es/node/11616
Mubarak Umar, Ph.D., is a member of Dr. Hafner's RNA Molecular Biology Group. He is studying the roles of RNA Guanine-quadruplex structures (rG4s) binding proteins in posttranscriptional regulation.